SCHEMBL4174623

SCHEMBL4174623

CC1C2CCC(C)(C2)C1(C)C

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
APOBEC3A P31941 1/20 0.30
CTDSP1 Q9GZU7 1/20 0.30
APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL5035447 0.97
SCHEMBL322133 0.78 ALDH1A1 (0.36)
SCHEMBL6600194 0.78
SCHEMBL4817757 0.77 SIGMAR1 (0.32)
SCHEMBL7395108 0.73 MAPK1 (0.41)
SCHEMBL7149332 0.72
SCHEMBL9788201 0.69
SCHEMBL9443936 0.69 APLNR (0.35)
SCHEMBL2563670 0.68 ALOX15 (0.41)
SCHEMBL2160121 0.68 CYP1A2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102548550-A Methods, uses and compounds for the treatment of exo-S-mecamylamine TARGACEPT INC 2012-07-04 CN disclosed
US-20090004508-A1 Thin-film materials, thin films and producing method thereof DAICEL CHEMICAL INDUSTRIES, LTD. 2009-01-01 US disclosed
EP-2003123-A2 Thin-film materials, thin films and producing method thereof Daicel Chemical Industries, Ltd. (JP) 2008-12-17 EP disclosed
US-20070078256-A1 Prepolymers, prepolymer compositions, high-molecular-weight polymers with pore structure, and dielectric films DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2007-04-05 US disclosed
EP-1683822-A1 PREPOLYMER, PREPOLYMER COMPOSITION, HIGH MOLECULAR WEIGHT POLYMER HAVING STRUCTURE CONTAINING HOLE AND ELECTRICALLY INSULATING FILM Daicel Chemical Industries, Ltd. (JP) 2006-07-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090004508-A1 Thin-film materials, thin films and producing method thereof RASSF2, NRAS, RASSF5 APOBEC3A 2854/4885CTDSP1 3993/4885APOBEC3G 3859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.